High Content Screening: TrendBio partner with Yokogawa Life Sciences

17 June 2019

We are proud to announce a newly formed partnership with Yokogawa Life Sciences, Japan.

As of 2019, TrendBio will distribute and support Yokogawa’s High Content Analysis portfolio in Oceania, bringing to the region new generation developments in the area of automated confocal microscopy. Built upon Yokogawa’s superb dual spinning disk technology, this partnership strengthens TrendBio’s existing cell biology portfolio by enabling high quality fluorescence, label free and 3D imaging application capabilities.

We are excited about upcoming future developments in this area which will see advancements in machine learning analysis tools as well as integration of multi-omics modalities.

Explore Yokogawa’s High Content Analysis portfolio in the Learn More section below.

The CV8000 features a cell incubator with an improved airtight design that facilitates the observation of cell behavior over long periods of time. In addition, the CV8000 comes with CellPathfinder, a new program that can analyze images of unlabeled cells and 3D images of samples.
Matias Abregu